Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Vesicoureteral reflux (VUR) in children: antibiotic prophylaxis is not effective in preventing complications

30.05.2008
Continuous antibiotic prophylaxis is not effective in preventing severe complications such as acute pyelonephritis (inflammation of kidney and renal pelvis) in children with vesicoureteral reflux (VUR).

This result stems from a randomized controlled trial led by the Institute of Child Health Burlo Garofolo (ICHBG) in Trieste (Italy) that lasted 6 years (2 years of investigation and 4 years of follow-up).

This study put an end to a long-lasting debate on the effectiveness of antibiotic prophylaxis in preventing the recurrences of urinary tract infections. The study, performed in 6 Paediatrics Hospitals in Northern Italy (Pordenone, Monfalcone, San Daniele, Tolmezzo, Cesena and Bologna), was published in the journal Pediatrics.

Vesicoureteral reflux is quite a common congenital anomaly in infancy. It is caused by the delay in the vesico-ureteral junction maturation that causes urine to flow towards the kidneys. This event may promote the onset of urinary tract infections that might be complicated by pyelonephritis, a severe and often recurrent renal inflammation. The disease usually resolves by the age of 10-12 years even in more severe cases, but in the meantime recurrent episodes of pyelonephritis may damage the renal function and lead to chronic renal failure.

Despite the lack of evidence about a causative relationship between VUR and recurrent pyelonephritis, the common clinical approach to vesicoureteral reflux was based on the use of long (many years) and continuous antibiotic prophylaxis even in asymptomatic children. It was commonly thought that this treatment could avoid renal involvement.

The multicentric study coordinated by the Institute of Child Health Burlo Garofolo in Trieste proves the ineffectiveness of this strategy and confirms the hypothesis that the better way to treat pyelonephritis in children with VUR is an early diagnosis followed by a single cycle of a specific antibiotic.

As Marco Pennesi, head of the Nephrology Unit of the Pediatric Department of ICHBG, says: “This trial puts two head points in the treatment of pyelonephritis in children with VUR. First of all, it shows that antibiotic prophylaxis is unhelpful in preventing acute recurrent renal inflammation; second of all, it study confirms that the standard approach (antibiotic prophylaxis) does not modify the natural history of the disease as it doesn’t significantly lower the incidence of renal damage evidenced by the presence of renal scars. Moreover, in contrast to other investigations that examined very heterogeneous populations (infants aged six months to boys of 18 years), this trial clearly spots the class of age at higher risk for complications, the one that really needs an early intervention: children under 30 months of age”

The trial enrolled 100 children under 30 months of age affected by proved VUR, who were randomized to be treated or not with the antibiotic prophylaxis. At the end of the study, the researchers didn’t find any significant difference between the two groups in terms of pyelonephritis or presence of more renal scars.

“Data collected in these 6 years – states Alessandro Ventura, Director of the Pediatric Clinic of the University of Trieste, located at the ICHBG – show that VUR by itself is not a risk factor for recurrent pyelonephritis as previously thought. Now it is of critical importance to add this new piece of evidence to the paediatric guidelines and to make Paediatricians aware of these new findings”.

Cristina Serra | alfa
Further information:
http://pediatrics.aappublications.org/cgi/content/abstract/peds.2007-2652v1?papetoc

More articles from Studies and Analyses:

nachricht New study: How does Europe become a leading player for software and IT services?
03.04.2017 | Fraunhofer-Institut für System- und Innovationsforschung (ISI)

nachricht Reusable carbon nanotubes could be the water filter of the future, says RIT study
30.03.2017 | Rochester Institute of Technology

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Wafer-thin Magnetic Materials Developed for Future Quantum Technologies

Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.

Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...

Im Focus: World's thinnest hologram paves path to new 3-D world

Nano-hologram paves way for integration of 3-D holography into everyday electronics

An Australian-Chinese research team has created the world's thinnest hologram, paving the way towards the integration of 3D holography into everyday...

Im Focus: Using graphene to create quantum bits

In the race to produce a quantum computer, a number of projects are seeking a way to create quantum bits -- or qubits -- that are stable, meaning they are not much affected by changes in their environment. This normally needs highly nonlinear non-dissipative elements capable of functioning at very low temperatures.

In pursuit of this goal, researchers at EPFL's Laboratory of Photonics and Quantum Measurements LPQM (STI/SB), have investigated a nonlinear graphene-based...

Im Focus: Bacteria harness the lotus effect to protect themselves

Biofilms: Researchers find the causes of water-repelling properties

Dental plaque and the viscous brown slime in drainpipes are two familiar examples of bacterial biofilms. Removing such bacterial depositions from surfaces is...

Im Focus: Hydrogen Bonds Directly Detected for the First Time

For the first time, scientists have succeeded in studying the strength of hydrogen bonds in a single molecule using an atomic force microscope. Researchers from the University of Basel’s Swiss Nanoscience Institute network have reported the results in the journal Science Advances.

Hydrogen is the most common element in the universe and is an integral part of almost all organic compounds. Molecules and sections of macromolecules are...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Dortmund MST Conference presents Individualized Healthcare Solutions with micro and nanotechnology

22.05.2017 | Event News

Innovation 4.0: Shaping a humane fourth industrial revolution

17.05.2017 | Event News

Media accreditation opens for historic year at European Health Forum Gastein

16.05.2017 | Event News

 
Latest News

New approach to revolutionize the production of molecular hydrogen

22.05.2017 | Materials Sciences

Scientists enlist engineered protein to battle the MERS virus

22.05.2017 | Life Sciences

Experts explain origins of topographic relief on Earth, Mars and Titan

22.05.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>